You are here
AusPAR: Meningococcal Polysaccharide Tetanus Toxoid Conjugate Vaccine
Related information
How to access a pdf or Word document
*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.
Australian Public Assessment Report
23 March 2021
| AusPAR | |
|---|---|
| Active Ingredient | Meningococcal Polysaccharide Tetanus Toxoid Conjugate Vaccine
|
| Product Name | MenQuadfi
|
| Sponsor | Sanofi-Aventis Australia Pty Ltd
|
| Submission Number | PM-2019-04826-1-2
|
| Submission Type | New biological entity
|
| Decision | Approved
|
| AusPAR Date | 17 March 2021
|
| Publication Date | 23 March 2021 |